Why the study?
Does daily low-dose aspirin prevent morbidity and mortality from preeclampsia?
Does daily low-dose aspirin prevent morbidity and mortality from preeclampsia?
Daily low-dose aspirin starting in the second trimester prevents clinically important health outcomes related to preeclampsia without identified harms.
Answers are grounded in this paper and cite their sources.
Supports low-dose aspirin from the second trimester in at-risk pregnancies; confirms benefit without harms in Level 1 evidence.
Daily low-dose aspirin beginning as early as the second trimester prevented clinically important health outcomes. No harms were identified, but long-term evidence was limited.
No takes yet. Share an insight, caveat, or question.
Henderson et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: